Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

docetaxel

  • Open Access
    Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
    YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, KOHEI MIZUTA, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research November 2025, 45 (11) 5225-5231; DOI: https://doi.org/10.21873/anticanres.17862
  • You have access
    Patients Diagnosed With Metastatic Castration-sensitive Prostate Cancer and High Serum Lactate Dehydrogenase Levels Did Not Receive an Adequate Dose of Cabazitaxel
    YASUSHI NAKAI, KENTA ONISHI, YORIAKI KAGEBAYASHI, KEN FUJIMOTO, AKIHIDE HIRAYAMA, MASAKI HARAMOTO, ATSUSHI TOMIOKA, KENJI OTSUKA, EIJIRO OKAJIMA, TAKESHI OTANI, YOSHIHIRO MATSUMOTO, YUKINARI HOSOKAWA, MASAHIRO TANAKA, TOSHIHISA SAKA, NOBUO OYAMA, SHUYA HIRAO, KIYOHIDE FUJIMOTO and NOBUMICHI TANAKA
    Anticancer Research September 2025, 45 (9) 3953-3960; DOI: https://doi.org/10.21873/anticanres.17753
  • Open Access
    Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer
    DIRK RADES, TOBIAS BARTSCHT, ACHIM RODY and MARTIN BALLEGAARD
    Anticancer Research May 2025, 45 (5) 2115-2121; DOI: https://doi.org/10.21873/anticanres.17586
  • You have access
    Evaluation of Candidates for Upfront Docetaxel Therapy Among Patients With Metastatic Castration-sensitive Prostate Cancer from a Retrospective Multicenter Study (MAHOROBA study)
    YASUSHI NAKAI, KENTA ONISHI, TOMONORI NAKAHAMA, YORIAKI KAGEBAYASHI, KEN FUJIMOTO, AKIHIDE HIRAYAMA, ATSUSHI TOMIOKA, KENJI OTSUKA, TAKESHI OTANI, YOSHIHIRO MATSUMOTO, MASAHIRO TANAKA, NOBUO OYAMA, KIYOHIDE FUJIMOTO and NOBUMICHI TANAKA
    Anticancer Research April 2025, 45 (4) 1653-1660; DOI: https://doi.org/10.21873/anticanres.17546
  • You have access
    Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC
    LI-KUO KUO, YU-KE FU, CHIEN-CHIH YEH, CHING-YI LEE, CHI-JUNG CHUNG, LI-JANE SHIH, HSIN-YING LU and CHIH-PIN CHUU
    Anticancer Research November 2024, 44 (11) 4915-4928; DOI: https://doi.org/10.21873/anticanres.17317
  • You have access
    MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
    MINJI KWON, DAYEON LIM, JAYEON PARK, WORLD GIL, JIWOO JUNG, SUYEON JUNG, CHAEEON KIM, MINJEONG GO, YE HWANG CHEONG, HEE SUN PARK, YONG-BIN EOM and SIN-AYE PARK
    Anticancer Research October 2024, 44 (10) 4283-4299; DOI: https://doi.org/10.21873/anticanres.17258
  • Open Access
    4-Cholesten-3-one Modified the Lipidome of MDA-MB-231 Cells and Potentiated the Effect of Docetaxel
    SRISTY SAHA, MIKAËL CROYAL, JEAN-MICHEL HUVELIN and HASSAN NAZIH
    Anticancer Research August 2024, 44 (8) 3277-3285; DOI: https://doi.org/10.21873/anticanres.17146
  • You have access
    MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
    TAYLOR AMERY, SHAADI TABATABAEI, MAYA SONPATKI, EVAN Y. YU and TOMASZ M. BEER
    Anticancer Research May 2024, 44 (5) 2247-2248; DOI: https://doi.org/10.21873/anticanres.17033
  • You have access
    Manganese as a Possible Anticancer Enhancer in Docetaxel Treatment of Prostate Cancer Cells
    INGVAR HOLM, BODIL HERNROTH, AMANDA ROSANDER and HELENA TASSIDIS
    Anticancer Research March 2024, 44 (3) 953-962; DOI: https://doi.org/10.21873/anticanres.16890
  • You have access
    Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    MASAAKI YAMAMOTO, TAKESHI OMORI, NAOKI SHINNO, HISASHI HARA, YOSUKE MUKAI, TAKAHITO SUGASE, TOMOHIRA TAKEOKA, MANABU MIKAMORI, TAKASHI KANEMURA, SHINICHIRO HASEGAWA, HIROFUMI AKITA, NAOTSUGU HARAGUCHI, JUNICHI NISHIMURA, HIROSHI WADA, CHU MATSUDA, MASAYOSHI YASUI, HIROSHI MIYATA and MASAYUKI OHUE
    Anticancer Research November 2023, 43 (11) 5015-5024; DOI: https://doi.org/10.21873/anticanres.16700

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire